Adc Therapeutics Sa (ADCT)
$1.53 +2.68% Close Oct 30, 2026 Live
Adc Therapeutics Sa stock today
Adc Therapeutics Sa closed at $1.53 on October 30, 2026, up 2.68% on the day. Over the past year it returned -67.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $195 million.
$2.00$4.00
NovJan 2026MarMayJulSep
| Period | ADCT | S&P 500 (SPY) |
|---|---|---|
| 1 month | +25.4% | -0.9% |
| 3 months | +37.8% | +2.1% |
| Year to date | -56.7% | +11.7% |
| 1 year | -67.0% | +12.4% |
| 3 years | +117.6% | +88.5% |
| 5 years | -94.7% | +76.0% |
Key statistics
- Market value
- $195M
- Price / sales
- 2.5
- 52-week range
- $0.96 to $4.88
- Next report
- Nov 10, 2026
About Adc Therapeutics Sa
Develops and commercializes oncology and cancer therapeutics.
Sector: Health Care
More on Adc Therapeutics Sa
- Financials: revenue, earnings and segmentsRevenue +15% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $52.78 today
No forecast, no recommendation. This page describes Adc Therapeutics Sa from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.